Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

Market Cap	3.88B
Revenue (ttm)	349.23M
Net Income (ttm)	10.56M
Shares Out	222.97M
EPS (ttm)	0.05
PE Ratio	367.45
Forward PE	n/a
Dividend	0.12 (0.70%)
Ex-Dividend Date	n/a

Volume	2,779,549
Average Volume	1,833,164
Open	17.24
Previous Close	17.17
Day's Range	17.15 - 17.77
52-Week Range	15.31 - 21.50
Beta	0.84
RSI	43.38
Earnings Date	Apr 25, 2025

About SHE:002932

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic products China and internationally. Its products portfolio includes molecular diagnostic products, such as PCR system, nucleic acid extraction and purification instrument, and sample release reagent; blood gas analyzer; immuno diagnosis, including chemiluminescence immunoassay, fluorescence immunity, and immunoquantitative analyzer; and automatic coagulation analyzer. The company also provides emergency and critical il...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 1,063
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002932

Financial Performance

In 2023, SHE:002932's revenue was 749.54 million, a decrease of -92.88% compared to the previous year's 10.53 billion. Earnings were 74.93 million, a decrease of -98.22%.